Sabina Janciauskiene

Medicin och livsvetenskap

1. alpha 1-Antitrypsin 100%
2. Monocytes 51%
3. Alzheimer Disease 37%
4. alpha 1-Antitrypsin Deficiency 33%
5. Secretory Leukocyte Peptidase Inhibitor 26%
6. Serine Proteinase Inhibitors 26%
7. In Vitro Techniques 26%
8. Tumor Necrosis Factor-alpha 24%
9. Peptides 23%
10. Atorvastatin 22%
11. Cerebrospinal Fluid 20%
12. Chemokine CCL2 19%
13. oxidized alpha-1-antitrypsin 19%
14. amyloid beta-protein (1-42) 17%
15. Interleukin-8 17%
16. Pravastatin 17%
17. Hydroxymethylglutaryl-CoA Reductase Inhibitors 16%
18. Neutrophils 16%
19. oxidized low density lipoprotein 16%
20. Peptide Hydrolases 16%
21. Crohn Disease 15%
22. Anti-Inflammatory Agents 15%
23. Fibromyalgia 15%
24. NF-kappa B 14%
25. Cytokines 13%
26. Protease Inhibitors 13%
27. PPAR gamma 13%
28. Chronic Obstructive Pulmonary Disease 13%
29. Dementia 13%
30. Endotoxins 12%
31. Intercellular Adhesion Molecule-1 12%
32. alpha 1-Antichymotrypsin 11%
33. Cognitive Dysfunction 11%
34. Cystatin C 10%
35. Lipopolysaccharides 10%
36. Interleukin-6 10%
37. Enzyme-Linked Immunosorbent Assay 9%
38. Lung 9%
39. Peptidyl-Dipeptidase A 9%
40. human NR5A2 protein 9%
41. Astrocytes 8%
42. Serpins 8%
43. Down-Regulation 8%
44. Polymers 7%
45. Glioma 7%
46. Cell Culture Techniques 7%
47. Inflammation 7%
48. Apoptosis 7%
49. endotoxin receptor 7%
50. Biomarkers 7%